[1]Wild S,Roglic G,Green A,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabetes Care,2004,27(5):1047-1053.[2]Yang W,Lu J,Weng J,et al. Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.[3]Mathew M,Tay E,Cusi K.Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation,myeloperoxidase and PAI-1 in healthy subjects[J]. Cardiovasc Diabetol,2010,9:9.[4]Paolisso G,Tataranni PA,Foley JE,et al. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for development of NIDDM[J]. Diabetologia,1995,38(10):1213 - 1217. [5]Matthews DR,Hosker JP,Rudenski AS,et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [J].Diabetologia,1985,28(7):412-419.[6]Haffner SM,Kennedy E,Gonzalez C,et al. A prospective analysis of the HOMA model. The Mexico city diabetes study [J]. Diabetes Care,1996,19 (10):1138-1141.[7]Boden G.Obesity and free fatty acids[J]. Endocrinol Metab Clin North Am,2008,37(3):635-646.[8]Oh DY,Lagakos WS. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity[J].Curr Opin Clin Nutr Metab Care,2011,14(4):322-327.[9]Del Guerra S,Bugliani M,D′Aleo V,et al. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids[J].Nutr Metab Cardiovasc Dis,2010,20(1):22-25.[10]DeFronzo RA.Insulin resistance,lipotoxicity,type 2 diabetes and atherosclerosis: the missing links[J]. Diabetologia,2010,53(7):1270-1287.